Elevance Health, Inc.

Market Summary

USD477.13+0.17

Delayedas of 08 Dec 2023, 03:23 pm

0.04%

ELV Alerts

1 major insider sales recently.

ELV Stock Price

View Fullscreen

ELV RSI Chart

ELV Alerts

1 major insider sales recently.

ELV Valuation

Market Cap

112.0B

Price/Earnings (Trailing)

18.61

Price/Sales (Trailing)

0.66

EV/EBITDA

9.58

Price/Free Cashflow

13.59

ELV Price/Sales (Trailing)

ELV Profitability

Free Cashflow Yield

7.36%

ELV Fundamentals

ELV Revenue

Revenue (TTM)

168.6B

Revenue Y/Y

7.29%

Revenue Q/Q

-1.88%

ELV Earnings

Earnings (TTM)

6.0B

Earnings Y/Y

-19.59%

Earnings Q/Q

-30.55%

Price Action

52 Week Range

412.00498.40

(Low)(High)

Last 7 days

-0.5%

Last 30 days

4.3%

Last 90 days

6.3%

Trailing 12 Months

-5.0%

How does ELV drawdown profile look like?

ELV Financial Health

ELV Investor Care

Dividend Yield

1.2%

Dividend/Share (TTM)

5.72

Buy Backs (1Y)

1.70%

Diluted EPS (TTM)

25.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	160.7B	165.7B	168.6B	0
2022	144.3B	149.1B	153.2B	156.6B
2021	124.6B	129.2B	133.9B	138.6B
2020	109.2B	113.0B	117.5B	121.9B
2019	94.2B	96.8B	100.2B	104.2B
2018	90.1B	90.6B	91.4B	92.1B
2017	87.1B	88.1B	89.1B	90.0B
2016	80.4B	81.8B	83.3B	84.9B
2015	75.1B	76.6B	78.0B	79.2B
2014	71.3B	72.1B	72.8B	73.9B
2013	63.7B	66.0B	68.6B	71.0B
2012	61.2B	61.5B	61.4B	61.5B
2011	58.5B	59.2B	60.0B	60.7B
2010	65.0B	64.0B	63.1B	58.7B
2009	60.8B	60.6B	61.1B	65.0B
2008	61.2B	61.2B	61.2B	61.3B
2007	0	0	0	61.2B

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for ELV

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Dec 01, 2023	todt blair williams	sold (taxes)	-56,041	483	-116	evp, clo & cao
Nov 30, 2023	penczek ronald w	sold	-501,304	475	-1,055	cao & controller
Nov 01, 2023	kendrick charles morgan jr	sold (taxes)	-35,286	446	-79.00	evp & president, commercial
Nov 01, 2023	haytaian peter d	sold (taxes)	-68,785	446	-154	evp & pres carelon & carelonrx
Oct 24, 2023	penczek ronald w	sold	-29,078	454	-64.00	cao & controller
Oct 02, 2023	kaye mark	acquired	-	-	20,276	evp & cfo designate
Jul 21, 2023	dixon robert l jr	sold	-147,780	476	-310	-
May 10, 2023	dixon robert l jr	acquired	-	-	457	-
May 10, 2023	clark r kerry	acquired	-	-	457	-
May 10, 2023	hay lewis iii	acquired	-	-	457	-

Which funds bought or sold ELV recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	Raleigh Capital Management Inc.	added	2.74	2,060	293,358	0.16%
Dec 06, 2023	CITIGROUP INC	reduced	-8.94	-11,705,300	97,122,200	0.07%
Dec 04, 2023	TUCKER ASSET MANAGEMENT LLC	new	-	1,910	1,910	-%
Dec 04, 2023	TUCKER ASSET MANAGEMENT LLC	new	-	943	943	-%
Dec 01, 2023	PFS Partners, LLC	unchanged	-	-185	10,923	0.01%
Dec 01, 2023	B. Riley Wealth Advisors, Inc.	reduced	-70.71	-3,087,420	1,243,310	0.03%
Dec 01, 2023	Fortis Group Advisors, LLC	new	-	5,660	5,660	-%
Nov 30, 2023	Scarborough Advisors, LLC	sold off	-100	-203,929	-	-%
Nov 30, 2023	Modera Wealth Management, LLC	added	2.00	-3,266	9,741,350	0.18%
Nov 30, 2023	Neo Ivy Capital Management	sold off	-100	-2,848,000	-	-%

Latest Funds Activity

Are funds buying ELV calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ELV

No. of Funds

Schedule 13G FIlings of Elevance Health, Inc.

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	price t rowe associates inc /md/	5.3%	12,717,041	SC 13G
Feb 09, 2023	vanguard group inc	8.99%	21,473,444	SC 13G/A
Jan 27, 2023	blackrock inc.	9.0%	21,566,516	SC 13G/A
Jan 25, 2023	blackrock inc.	9.0%	21,566,516	SC 13G/A

Recent SEC filings of Elevance Health, Inc.

View All Filings

Date Filed	Form Type	Document
Dec 05, 2023	4	Insider Trading
Dec 01, 2023	4	Insider Trading
Nov 30, 2023	144	Notice of Insider Sale Intent
Nov 03, 2023	4	Insider Trading
Nov 03, 2023	4	Insider Trading
Nov 01, 2023	S-3ASR	S-3ASR
Oct 26, 2023	4	Insider Trading
Oct 18, 2023	8-K	Current Report
Oct 18, 2023	10-Q	Quarterly Report
Oct 13, 2023	8-K	Current Report

Elevance Health, Inc. News

Latest updates

Nasdaq • 08 Dec 2023 • 07:00 pm • 94 minutes ago

Peter Lynch Detailed Fundamental Analysis - ELV

MarketBeat • 08 Dec 2023 • 02:21 pm • 6 hours ago

Schonfeld Strategic Advisors LLC Has $24.23 Million Position in ...

Nasdaq • 07 Dec 2023 • 04:16 pm • 28 hours ago

IWB, LOW, BKNG, ELV: Large Outflows Detected at ETF

MarketBeat • 07 Dec 2023 • 02:47 pm • 29 hours ago

Cooperman Leon G Takes Position in Elevance Health, Inc. (NYSE ...

DirectorsTalk Interviews • 07 Dec 2023 • 01:23 pm • 31 hours ago

Elevance Health, Inc. - Consensus 'buy' rating and 17.4% Upside ...

Yahoo Finance • 07 Dec 2023 • 12:00 pm • 32 hours ago

Is Elevance Health, Inc.'s (NYSE:ELV) Recent Performance ...

Insider Monkey • 05 Dec 2023 • 04:16 pm • 3 days ago

12 Best Healthcare Dividend Stocks To Buy Now

Nasdaq • 04 Dec 2023 • 03:00 pm • 4 days ago

Validea's Top Health Care Stocks Based On Peter Lynch - 12/4/2023

Simply Wall St • 03 Dec 2023 • 02:14 pm • 5 days ago

Elevance Health, Inc.'s (NYSE:ELV) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Nasdaq • 01 Dec 2023 • 03:59 pm • 7 days ago

Ex-Dividend Reminder: Sempra, The Cigna Group and Elevance ...

MarketBeat • 30 Nov 2023 • 09:45 pm • 7 days ago

1832 Asset Management L.P. Buys 238989 Shares of Elevance ...

Nasdaq • 29 Nov 2023 • 12:22 pm • 9 days ago

Analysts Forecast 15% Gains Ahead For VLUE

Nasdaq • 29 Nov 2023 • 11:20 am • 9 days ago

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

Morningstar • 29 Nov 2023 • 08:00 am • 9 days ago

Cigna's and Humana's stock slides on report of deal talks

Nasdaq • 27 Nov 2023 • 08:00 am • 11 days ago

Validea's Top Health Care Stocks Based On Peter Lynch - 11/27/2023

Financials for Elevance Health, Inc.

Income Statement (Last 12 Months)
(In Millions)

Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	-1.9%	42,849	43,672	42,172	39,929	39,939	38,632	38,095	36,581	35,822	33,851	32,385	31,824	31,158	29,264	29,621	27,407	26,674	25,466	24,666	23,373	23,251
S&GA Expenses	13.5%	5,470	4,818	4,800	4,567	4,516	4,272	4,345	4,226	3,946	3,821	3,925	4,318	5,305	4,046	3,781	3,502	3,418	3,278	3,166	3,618	3,546
Interest Expenses	-0.8%	259	261	251	229	213	208	201	200	201	205	192	191	198	201	194	190	185	184	187	189	188
Income Taxes	-39.5%	354	585	615	168	529	488	527	291	494	552	509	60.00	167	873	566	164	306	314	394	118	282
Earnings Before Taxes	-32.2%	1,654	2,441	2,619	1,045	2,127	2,122	2,306	1,470	1,996	2,353	2,176	611	389	3,149	2,089	1,098	1,489	1,453	1,945	542	1,242
Net Income	-30.5%	1,289	1,856	2,004	872	1,603	1,634	1,779	1,186	1,509	1,801	1,667	551	222	2,276	1,523	934	1,183	1,139	1,551	424	960

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	1.2%	110,478	109,168	109,040	102,755	103,026	100,877	100,486	97,456	98,060	96,097	95,683	86,615	86,574	87,976	82,399	77,453	77,809	75,851	74,523	71,571	74,445
Current Assets	2.4%	61,185	59,743	59,823	55,617	55,603	53,655	53,897	51,122	51,904	50,238	54,495	45,751	45,450	46,764	41,256	39,033	39,504	37,805	36,611	34,321	37,108
Cash Equivalents	9.3%	10,919	9,991	10,142	7,387	8,872	6,456	6,161	4,880	5,490	5,258	9,326	5,741	3,984	6,028	5,345	4,937	4,190	4,078	4,482	3,934	4,260
Net PPE	-6.6%	4,248	4,547	4,418	4,316	4,197	4,090	3,986	3,919	3,835	3,733	3,533	3,483	3,363	3,427	3,350	3,133	2,921	2,837	2,799	2,735	2,592
Goodwill	0.1%	25,291	25,274	25,273	24,383	24,381	24,367	24,251	24,228	24,184	24,399	21,708	21,691	21,687	21,641	21,661	20,500	20,500	20,500	20,500	20,504	20,468
Liabilities	1.5%	71,939	70,856	71,580	66,425	66,983	65,010	64,455	61,293	62,252	61,051	61,765	53,416	52,653	53,521	50,706	45,725	46,477	45,058	44,525	43,030	45,351
Current Liabilities	4.2%	43,337	41,571	41,889	39,696	41,287	39,308	39,733	34,885	35,162	33,794	34,749	29,453	28,561	28,522	27,039	23,532	23,234	23,090	22,682	21,965	24,174
Short Term Borrowings	-100.0%	-	265	265	265	265	175	275	275	175	175	-	-	150	-	1,075	700	710	1,010	1,095	1,145	1,270
LT Debt, Current	-	799	-	-	1,500	2,249	2,248	3,097	1,599	849	849	700	700	1,599	1,603	1,603	1,598	700	850	851	849	849
LT Debt, Non Current	-3.3%	24,045	24,859	25,201	22,349	21,258	21,165	19,883	21,157	21,761	22,217	22,534	19,335	19,094	19,873	19,005	17,787	18,820	17,436	17,396	17,217	17,300
Shareholder's Equity	0.3%	38,423	38,312	37,460	36,243	36,055	35,887	36,059	36,095	35,808	35,046	33,918	33,187	33,921	34,455	31,693	31,693	31,332	30,793	29,998	28,567	29,094
Retained Earnings	1.6%	32,103	31,608	30,707	29,647	29,604	28,825	28,058	27,142	26,700	25,874	24,793	23,802	24,678	25,346	23,360	22,573	22,104	21,679	21,136	19,988	20,182
Additional Paid-In Capital	0.8%	8,830	8,761	8,697	9,084	9,169	9,134	9,151	9,148	9,138	9,109	9,253	9,244	9,352	9,360	9,338	9,448	9,524	9,494	9,482	9,536	9,720
Shares Outstanding	-0.4%	235	236	237	238	239	240	241	242	243	244	245	245	249	252	252	253	254	256	257	257	259
Minority Interest	8.4%	116	107	104	87.00	52.00	55.00	56.00	68.00	71.00	78.00	65.00	-	-	-	-	-	-	-	-	-	-

Cashflow (Last 12 Months)
(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	34.0%	2,613	1,950	6,469	-1,518	4,924	2,452	2,541	1,672	2,504	1,683	2,505	3,813	-1,150	5,510	2,515	1,327	1,667	1,437	1,630	463	607
Share Based Compensation	0%	78.00	78.00	61.00	73.00	69.00	72.00	50.00	59.00	63.00	69.00	64.00	69.00	80.00	67.00	67.00	68.00	86.00	70.00	70.00	91.00	57.00
Cashflow From Investing	-2.2%	-687	-672	-3,184	289	-1,247	-2,024	-1,578	-966	-1,440	-4,925	-2,307	305	89.00	-4,934	-2,784	723	-1,698	-1,165	-652	773	-688
Cashflow From Financing	30.5%	-994	-1,430	-531	-258	-1,255	-127	322	-1,315	-830	-820	3,388	-2,367	-984	105	679	-1,304	144	-677	-429	-1,561	-340
Dividend Payments	-0.6%	348	350	351	305	306	309	309	273	276	278	277	234	238	242	240	202	204	206	206	193	195
Buy Backs	-25.6%	485	652	622	568	579	624	545	522	451	480	447	1,358	758	55.00	529	305	644	458	294	493	397

ELV Income Statement

2023-09-30

10-Q Consolidated Statements Of Income - USD ($) $ in Millions	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues
Premiums	$ 35,259			$ 33,722			$ 107,716	$ 99,583	$ 133,229	$ 117,373	$ 104,109
Product revenue	5,177			3,972			14,058	10,841	14,978	12,657	10,384
Service fees	2,044			1,931			5,981	5,569	7,453	6,913	6,315
Total operating revenue	42,480			39,625			127,755	115,993	155,660	136,943	120,808
Net investment income	493			371			1,296	1,112	1,485	1,378	877
Net losses on financial instruments	(124)			(57)			(358)	(439)	(550)	318	182
Total revenues	42,849			39,939			128,693	116,666	156,595	138,639	121,867
Expenses
Benefit expense	30,606	$ 31,604	$ 30,786	29,421	$ 28,795	$ 28,231	92,996	86,447	116,642	102,571	88,045
Cost of products sold	4,648			3,437			12,456	9,389	13,035	10,895	8,953
Operating expense	5,470			4,516			15,088	13,133	17,700	15,918	17,450
Interest expense	259			213			771	622	851	798	784
Amortization of other intangible assets	212			225			668	520	767	441	361
Total expenses	41,195			37,812			121,979	110,111	148,995	130,644	115,629
Income before income tax expense	1,654			2,127			6,714	6,555	7,600	7,995	6,238
Income tax expense	354			529			1,554	1,544	1,712	1,846	1,666
Net income	1,300	$ 1,856	$ 2,004	1,598	$ 1,634	$ 1,779	5,160	5,011	5,888	6,149	4,572
Net (income) loss attributable to noncontrolling interests	(11)			5			(29)	18	6	9	0
Shareholders’ net income	$ 1,289			$ 1,603			$ 5,131	$ 5,029	$ 5,894	$ 6,158	$ 4,572
Shareholders’ net income per share
Basic net income per share	$ 5.48			$ 6.69			$ 21.70	$ 20.91	$ 24.56	$ 25.26	$ 18.23
Diluted net income per share	5.45			6.62			21.56	20.67	24.28	24.95	17.98
Dividends per share	$ 1.48			$ 1.28			$ 4.44	$ 3.84	$ 5.12	$ 4.52	$ 3.80

ELV Balance Sheet

2023-09-30

10-Q Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 10,919			$ 7,387				$ 4,880
Fixed maturities, current	27,811			25,952				26,267
Equity securities	165			953				1,881
Premium receivables	7,883			7,083				5,681
Self-funded receivables	3,756			4,663				4,010
Other receivables	5,293			4,298				3,749
Other current assets	5,358			5,281				4,654
Total current assets	61,185			55,617				51,122
Long-term investments:
Fixed maturities, long-term	816			752				632
Other invested assets	6,118			5,685				5,225
Property and equipment, net	4,248			4,316				3,919
Goodwill	25,291			24,383				24,228	$ 21,691
Other intangible assets	10,491			10,315				10,615
Other noncurrent assets	2,329			1,687				1,715
Total assets	110,478			102,755				97,456
Current Liabilities:
Medical claims payable	16,176			15,596				13,518
Other policyholder liabilities	5,681			5,933				5,521
Unearned income	4,332			1,112				1,153
Accounts payable and accrued expenses	5,983			5,607				4,970
Short-term borrowings	0			265				275
Current portion of long-term debt	799			1,500				1,599
Other current liabilities	10,366			9,683				7,849
Total current liabilities	43,337			39,696				34,885
Long-term debt, less current portion	24,045			22,349				21,157
Reserves for future policy benefits, noncurrent	807			803				753
Deferred tax liabilities, net	1,779			2,015				2,815
Other noncurrent liabilities	1,971			1,562				1,683
Total liabilities	71,939			66,425				61,293
Commitments and contingencies – Note 11
Preferred stock, shares issued	0			0				0
Preferred stock, shares outstanding	0			0				0
Shareholders' equity
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none	$ 0			$ 0				$ 0
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 234,906,987 and 237,958,067	2			2				2
Additional paid-in capital	8,830			9,084				9,148
Retained earnings	32,103			29,647				27,142
Accumulated other comprehensive loss	(2,512)	$ (2,166)		(2,490)	$ (2,779)	$ (2,151)		(197)	150	$ (296)
Total shareholders' equity	38,423			36,243	$ 36,055			36,095
Noncontrolling interests	116			87				68
Total equity	38,539	$ 38,312	$ 37,460	36,330		$ 35,887	$ 36,059	36,163	$ 33,187	$ 31,693
Total liabilities and shareholders' equity	$ 110,478			$ 102,755				$ 97,456

About Elevance Health, Inc.

Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.

CEO	Ms. Gail Koziara Boudreaux
WEBSITE	www.elevancehealth.com
EMPLOYEES	65535

Elevance Health, Inc. Frequently Asked Questions

What is the ticker symbol for Elevance Health, Inc.? What does ELV stand for in stocks?

ELV is the stock ticker symbol of Elevance Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Elevance Health, Inc. (ELV)?

As of Thu Dec 07 2023, market cap of Elevance Health, Inc. is 112.02 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ELV stock?

You can check ELV's fair value in chart. The fair value of Elevance Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Elevance Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ELV so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Elevance Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether ELV is over valued or under valued. Whether Elevance Health, Inc. is cheap or expensive depends on the assumptions which impact Elevance Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ELV.

What is Elevance Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, ELV's PE ratio (Price to Earnings) is 18.61 and Price to Sales (PS) ratio is 0.66. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ELV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Elevance Health, Inc.'s stock?

In the past 10 years, Elevance Health, Inc. has provided 0.194 (multiply by 100 for percentage) rate of return.

Market Summary

ELV Alerts

ELV Stock Price

ELV RSI Chart

ELV Alerts

ELV Valuation

ELV Price/Sales (Trailing)

ELV Profitability

ELV Fundamentals

ELV Revenue

ELV Earnings

Price Action

52 Week Range

How does ELV drawdown profile look like?

ELV Financial Health

ELV Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for ELV

Which funds bought or sold ELV recently?

Latest Funds Activity

Schedule 13G FIlings of Elevance Health, Inc.

Recent SEC filings of Elevance Health, Inc.

Elevance Health, Inc. News

Financials for Elevance Health, Inc.

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

ELV Income Statement

ELV Balance Sheet

About Elevance Health, Inc.

Elevance Health, Inc. Frequently Asked Questions

What is the ticker symbol for Elevance Health, Inc.? What does ELV stand for in stocks?

What is the market capital of Elevance Health, Inc. (ELV)?

What is the fair value of ELV stock?

Is Elevance Health, Inc. a good stock to buy?

What is Elevance Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on Elevance Health, Inc.'s stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)